The long-term remission of rheumatoid arthritis with a single cycle of rituximab
Introduction.Rituximab selectively targets CD20+ B cells and presumably protects joints in rheumatoid arthritis.Complete remissions after a single treatment with rituximab, in some cases for longer than 1 year, are observed in only click here the minority of patients.We reported a patient suffering from refractory rheumatoid arthritis who responded